Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp
- PMID: 23315061
- DOI: 10.1093/humrep/des463
Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp
Abstract
Study question: What is the prevalence of insulin resistance (IR) and the contributions of intrinsic and extrinsic IR in women diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria?
Summary answer: We report novel clamp data in Rotterdam diagnosed PCOS women, using World Health Organization criteria for IR showing that women with PCOS have a high prevalence of IR, strengthening the evidence for an aetiological role of IR in both National Institutes of Health (NIH) and Rotterdam diagnosed PCOS in lean and overweight women.
What is known already: PCOS is a complex endocrine condition with a significant increased risk of gestational diabetes and type 2 diabetes.
Study design, size, duration: Using a cross-sectional study design, 20 overweight and 20 lean PCOS (Rotterdam criteria), 14 overweight and 19 lean body mass index (BMI)-matched control non-PCOS women underwent clinical measures of IR after a 3-month withdrawal of insulin sensitizers and the oral contraceptive pill.
Materials, setting, methods: In an academic clinic setting, glucose infusion rate (GIR) on euglycaemic-hyperinsulinaemic clamp was investigated as a marker of insulin sensitivity.
Main results and the role of chance: PCOS women were more IR than BMI-matched controls (main effect for BMI and PCOS; P < 0.001). IR was present in 75% of lean PCOS, 62% of overweight controls and 95% of overweight PCOS. Lean controls (mean ± SD; GIR 339 ± 76 mg min⁻¹ m⁻²) were less IR than lean PCOS (270 ± 66 mg min⁻¹ m⁻²), overweight controls (264 ± 66 mg min⁻¹ m⁻²) and overweight PCOS (175 ± 96 mg min⁻¹ m⁻²). The negative relationship between BMI and IR reflected by GIR was more marked in PCOS (y = 445.1 - 7.7x, R² = 0.42 (P < 0.0001) than controls (y = 435.5 - 4.6x, R² = 0.04 (P < 0.01)).
Limitations, reasons for caution: The study did not use glucose tracer techniques to completely characterize the IR, as well as the lack of matching for body composition and age.
Wider implications of the findings: IR is exacerbated by increased BMI, supporting intrinsic IR in PCOS. BMI impact on IR is greater in PCOS, than in controls, irrespective of visceral fat, prioritizing lifestyle intervention and the need for effective therapeutic interventions to address intrinsic IR and prevent diabetes in this high-risk population.
Study funding/competing interest(s): This investigator-initiated trial was supported by grants from the National Health & Medical Research Council (NHMRC) Grant number 606553 (H.J.T., N.K.S. and S.K.H.) as well as Monash University and The Jean Hailes Foundation. H.J.T. is an NHMRC Research Fellow. N.K.S. is supported through the Australian Government's Collaborative Research Networks (CRN) programme. A.E.J. is a Jean Hailes and NHMRC scholarship holder. The authors declare that there is no conflict of interest associated with this manuscript.
Similar articles
-
Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies.Hum Reprod. 2016 Nov;31(11):2619-2631. doi: 10.1093/humrep/dew243. Epub 2016 Oct 7. Hum Reprod. 2016. PMID: 27907900
-
Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.Hum Reprod. 2013 Mar;28(3):785-93. doi: 10.1093/humrep/des456. Epub 2013 Jan 12. Hum Reprod. 2013. PMID: 23315058
-
The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.Hum Reprod. 2013 Aug;28(8):2276-83. doi: 10.1093/humrep/det256. Epub 2013 Jun 15. Hum Reprod. 2013. PMID: 23771201
-
Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.Hum Reprod. 2014 Jul;29(7):1526-35. doi: 10.1093/humrep/deu114. Epub 2014 May 19. Hum Reprod. 2014. PMID: 24842895
-
Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis.Hum Reprod. 2023 Jun 1;38(6):1168-1182. doi: 10.1093/humrep/dead053. Hum Reprod. 2023. PMID: 37015099 Free PMC article.
Cited by
-
The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment.Medicina (Kaunas). 2024 Oct 10;60(10):1656. doi: 10.3390/medicina60101656. Medicina (Kaunas). 2024. PMID: 39459443 Free PMC article. Review.
-
Inositols in the Treatment of Insulin-Mediated Diseases.Int J Endocrinol. 2016;2016:3058393. doi: 10.1155/2016/3058393. Epub 2016 Sep 8. Int J Endocrinol. 2016. PMID: 27688754 Free PMC article. Review.
-
Complications and challenges associated with polycystic ovary syndrome: current perspectives.Int J Womens Health. 2015 Jul 31;7:745-63. doi: 10.2147/IJWH.S70314. eCollection 2015. Int J Womens Health. 2015. PMID: 26261426 Free PMC article. Review.
-
Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes.Cureus. 2023 Jan 5;15(1):e33390. doi: 10.7759/cureus.33390. eCollection 2023 Jan. Cureus. 2023. PMID: 36751233 Free PMC article. Review.
-
Effect of Moderate Aerobic Exercise on Complement Activation Pathways in Polycystic Ovary Syndrome Women.Front Endocrinol (Lausanne). 2022 Feb 17;12:740703. doi: 10.3389/fendo.2021.740703. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35250845 Free PMC article.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous